Clinical Trials
4
Active:0
Completed:4
Trial Phases
0 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Assessment of EyeArt Performance With Retinal Cameras
Completed
- Conditions
- Diabetic Retinopathy
- Interventions
- Procedure: Retinal imagingDrug: Mydriatic Agent
- First Posted Date
- 2021-07-30
- Last Posted Date
- 2022-11-09
- Lead Sponsor
- Eyenuk, Inc.
- Target Recruit Count
- 246
- Registration Number
- NCT04984200
- Locations
- 🇺🇸
Rocky Mountain Diabetes Center, Idaho Falls, Idaho, United States
Assessment of EyeArt Performance With Retinal Imaging Devices
Completed
- Conditions
- Diabetic Retinopathy
- First Posted Date
- 2020-03-10
- Last Posted Date
- 2021-07-08
- Lead Sponsor
- Eyenuk, Inc.
- Target Recruit Count
- 62
- Registration Number
- NCT04302012
- Locations
- 🇺🇸
Lundquist Institute, Los Angeles, California, United States
Assessment of EyeArt as an Automated Diabetic Retinopathy Screening Tool
Completed
- Conditions
- Diabetic Eye ProblemsDiabetic RetinopathyDiabetic Macular Edema
- First Posted Date
- 2017-04-13
- Last Posted Date
- 2018-07-30
- Lead Sponsor
- Eyenuk, Inc.
- Target Recruit Count
- 942
- Registration Number
- NCT03112005
- Locations
- 🇺🇸
Los Angeles Biomedical Research Institute, Los Angeles, California, United States
Pilot Assessment of EyeArt as an Automated Diabetic Retinopathy Screening Tool
Completed
- Conditions
- Diabetic Retinopathy
- First Posted Date
- 2017-03-13
- Last Posted Date
- 2018-07-30
- Lead Sponsor
- Eyenuk, Inc.
- Target Recruit Count
- 52
- Registration Number
- NCT03078231
- Locations
- 🇺🇸
LAC+USC Medical Center, Los Angeles, California, United States
News
No news found